RxLightning automates the manual enrollment process of starting a patient on specialty medications.
RxLightning has raised $17.5M in total funding. The most recent round was Series A. The last funding was announced in June 2023.
RxLightning's investors include Novartis, LRVHealth, HealthX Ventures, XLerateHealth, Hearst Ventures.
RxLightning is headquartered in New Albany, United States.
RxLightning automates the manual enrollment process of starting a patient on specialty medications.
RxLightning is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RxLightning — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/rxlightning. Accessed August 14, 2026.
VCBacked. (2023). RxLightning — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/rxlightning
{{cite web |title=RxLightning — Funding & Investors |url=https://www.vcbacked.co/company/rxlightning |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated